Skip to main content

Core Scientific, Inc./tx (CORZ) Stock Forecast 2025 - AI Price Prediction & Analysis


Core Scientific, Inc./tx (CORZ) AI Stock Price Forecast & Investment Analysis

Core Scientific, Inc./tx Stock Price Chart and Technical Analysis

Loading Core Scientific, Inc./tx interactive price chart and technical analysis...

Core Scientific, Inc./tx (CORZ) - Comprehensive Stock Analysis & Investment Research

Deep dive into Core Scientific, Inc./tx's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Core Scientific, Inc./tx, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Core Scientific, Inc./tx: Core Scientific, Inc./tx operates in the Finance or Crypto Assets sector, establishing it as a mid-cap growth opportunity.

Core Scientific, Inc./tx (Stock Symbol: CORZ) is a leading company in the Finance or Crypto Assets sector , specifically operating within the Finance Services industry.

The organization employs approximately 205 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Core Scientific, Inc./tx's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Core Scientific, Inc./tx: With $557M in annual revenue and -221.3% net margin, the company demonstrates developing profitability.

Annual Revenue: $557 million generating a -221.3% net profit margin .

Market Capitalization: $4029 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -44.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Core Scientific, Inc./tx stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Core Scientific, Inc./tx: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Core Scientific, Inc./tx stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Core Scientific, Inc./tx's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Core Scientific, Inc./tx: Market positioning analysis based on available financial and operational metrics.

Core Scientific, Inc./tx strategically competes in the highly dynamic Finance Services marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 29.9% gross margin, indicating strong pricing power and operational efficiency.

Core Scientific, Inc./tx (CORZ) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Core Scientific, Inc./tx stock analysis.

Loading Core Scientific, Inc./tx comprehensive fundamental analysis and insider trading data...

Deep dive into Core Scientific, Inc./tx's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Core Scientific, Inc./tx stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Core Scientific, Inc./tx: With a P/E ratio of -1.31, the market sees the stock as potentially undervalued.

P/E Ratio -1.31x
P/B Ratio -22.20x
Market Cap $4029M
EPS $-5.39
Book Value/Share $-0.61
Revenue/Share $3.01
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Core Scientific, Inc./tx converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Core Scientific, Inc./tx: An ROE of -44.9% indicates room for improvement in shareholder value creation.

ROE -44.9%
ROA -18.7%
ROIC -21.2%
Gross Margin 29.9%
Operating Margin 6.4%
Net Margin -221.3%
EBT Margin -335.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Core Scientific, Inc./tx's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Core Scientific, Inc./tx: A current ratio of 1.95 shows adequate liquidity.

Current Ratio 1.95x
Quick Ratio 0.23x
D/E Ratio 0.98x
Financial Leverage 2.40x
Interest Coverage 0.4x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Core Scientific, Inc./tx's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Core Scientific, Inc./tx: Free cash flow of $-624M indicates cash challenges that need attention.

Operating Cash Flow $-21M
Free Cash Flow $-624M
Capital Spending $-603M
FCF/Sales -451.5%
CapEx/Sales 436.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Core Scientific, Inc./tx uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Core Scientific, Inc./tx: An asset turnover of 0.05x suggests room for improvement in asset utilization.

Asset Turnover 0.05x
Receivables Turnover 823.1x
Fixed Assets Turnover 0.2x
Days Sales Outstanding 0 days
Payables Period 64 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Core Scientific, Inc./tx's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Core Scientific, Inc./tx: With annual revenue of $557M, Core Scientific, Inc./tx demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $557M
Operating Income $35M
Net Income $-1233M
R&D Expense $9M
SG&A Expense $31M
Cost of Goods Sold $384M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 30%
Cash & Short-term Investments 4%
Total Liabilities 58%
Short-term Debt 4%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 299M
Growth Metrics (YoY)
EPS Growth -34.0%

Latest Core Scientific, Inc./tx Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Core Scientific, Inc./tx (CORZ) stock price and investment outlook.

📰 We are currently updating our news feed for Core Scientific, Inc./tx. Check back soon for the latest market analysis and company updates.

Core Scientific, Inc./tx Competitors & Peer Analysis - Finance or Crypto Assets Sector

Comparative analysis of Core Scientific, Inc./tx against industry peers and competitors in the Finance or Crypto Assets sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABTS Unlock Forecast - 30 Days FREE Trial $124M x 11.0x
AGRI Unlock Forecast - 30 Days FREE Trial $1M -0.3x 0.3x
AMBR Unlock Forecast - 30 Days FREE Trial $153M x 0.9x
ANY Unlock Forecast - 30 Days FREE Trial $18M -1.0x 0.6x
ASST Unlock Forecast - 30 Days FREE Trial $75M -0.5x 28.0x
ATCH Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
AXP Unlock Forecast - 30 Days FREE Trial $227362M 22.4x 7.0x
BCG Unlock Forecast - 30 Days FREE Trial $33M x 3.4x
BCGWW Unlock Forecast - 30 Days FREE Trial $0M x 0.1x
BEGI Unlock Forecast - 30 Days FREE Trial $1M x x
BENF Unlock Forecast - 30 Days FREE Trial $53M x -0.5x
BENFW Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
BKKT Unlock Forecast - 30 Days FREE Trial $0M -2.7x 0.0x
BMNR Unlock Forecast - 30 Days FREE Trial $97M x 33.9x
BTBT Unlock Forecast - 30 Days FREE Trial $787M x 1.2x
BTCM Unlock Forecast - 30 Days FREE Trial $2922M x 63.7x
BTCS Unlock Forecast - 30 Days FREE Trial $92M -4561.2x 3.0x
BTCT Unlock Forecast - 30 Days FREE Trial $8M x 0.4x
BTM Unlock Forecast - 30 Days FREE Trial $0M -1.6x 0.0x
BTMWW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BTOG Unlock Forecast - 30 Days FREE Trial $30M x 0.9x
BUR Unlock Forecast - 30 Days FREE Trial $3670M -41.7x 1.5x
CBLO Unlock Forecast - 30 Days FREE Trial $37M x x
CHYM Unlock Forecast - 30 Days FREE Trial $2343M x 1.6x
CIFR Unlock Forecast - 30 Days FREE Trial $2361M -121.5x 3.2x
CIFRW Unlock Forecast - 30 Days FREE Trial $309M x 0.5x
CLSK Unlock Forecast - 30 Days FREE Trial $3613M 768.6x 1.9x
CLSKW Unlock Forecast - 30 Days FREE Trial $131M x 0.1x
CMPO Unlock Forecast - 30 Days FREE Trial $0M 29.2x 0.0x
CMPOW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CNF Unlock Forecast - 30 Days FREE Trial $7008M x 1.8x
COEP Unlock Forecast - 30 Days FREE Trial $59M x 9.7x
COIN Unlock Forecast - 30 Days FREE Trial $88844M 31.1x 7.4x
COOP Unlock Forecast - 30 Days FREE Trial $14007M 24.6x 2.8x
CORZ Unlock Forecast - 30 Days FREE Trial $4029M -1.3x -22.2x
CORZW Unlock Forecast - 30 Days FREE Trial $1946M x -2.7x
CORZZ Unlock Forecast - 30 Days FREE Trial $3481M x -4.8x
CPSS Unlock Forecast - 30 Days FREE Trial $188M 9.7x 0.6x
CRCL Unlock Forecast - 30 Days FREE Trial $9779M x 4.1x
DAVE Unlock Forecast - 30 Days FREE Trial $0M 40.2x 0.0x
DAVEW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
EBFI Unlock Forecast - 30 Days FREE Trial $431M x 517.9x
ETHW Unlock Forecast - 30 Days FREE Trial $463M x x
EXOD Unlock Forecast - 30 Days FREE Trial $M x x
FETH Unlock Forecast - 30 Days FREE Trial $2160M x 1.7x
FGF Unlock Forecast - 30 Days FREE Trial $37M 6.2x 0.5x
FGFPP Unlock Forecast - 30 Days FREE Trial $36M 4.5x 0.5x
FLD Unlock Forecast - 30 Days FREE Trial $152M x 1.7x
FLDDU Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
FLDDW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
FUFU Unlock Forecast - 30 Days FREE Trial $616M x 3.1x
GDOT Unlock Forecast - 30 Days FREE Trial $581M -146.6x 0.6x
GHI Unlock Forecast - 30 Days FREE Trial $0M 11.0x 0.0x
GREE Unlock Forecast - 30 Days FREE Trial $20M -0.6x -0.4x
GREEL Unlock Forecast - 30 Days FREE Trial $136M -2.6x -1.9x
GRYP Unlock Forecast - 30 Days FREE Trial $511M 0.0x -1.3x
HIVE Unlock Forecast - 30 Days FREE Trial $513M x 0.9x
HUT Unlock Forecast - 30 Days FREE Trial $2253M x 2.4x
IREN Unlock Forecast - 30 Days FREE Trial $6740M x 3.7x
LDI Unlock Forecast - 30 Days FREE Trial $996M -4.1x 3.7x
LMFA Unlock Forecast - 30 Days FREE Trial $5M -0.5x 0.2x
MARA Unlock Forecast - 30 Days FREE Trial $6956M 10.3x 1.5x
MBNKO Unlock Forecast - 30 Days FREE Trial $847M 20.2x 2.2x
MBNKP Unlock Forecast - 30 Days FREE Trial $591M 14.9x 1.6x
MDBH Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
MFIN Unlock Forecast - 30 Days FREE Trial $351M 8.4x 0.9x
MGLD Unlock Forecast - 30 Days FREE Trial $45M -15.6x 1.8x
MGTE Unlock Forecast - 30 Days FREE Trial $182M x 0.4x
MGTEW Unlock Forecast - 30 Days FREE Trial $12M x 0.0x
MIGI Unlock Forecast - 30 Days FREE Trial $6M -0.4x -8.1x
ML Unlock Forecast - 30 Days FREE Trial $147M 354.3x 0.5x
MSTR Unlock Forecast - 30 Days FREE Trial $103883M 21.7x 2.2x
MVCO Unlock Forecast - 30 Days FREE Trial $M x x
NCPL Unlock Forecast - 30 Days FREE Trial $1M -0.4x 0.0x
NCPLW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
NCTY Unlock Forecast - 30 Days FREE Trial $M x x
OLKR Unlock Forecast - 30 Days FREE Trial $184M x x
OPFI Unlock Forecast - 30 Days FREE Trial $93M 21.2x 2.7x
OPRT Unlock Forecast - 30 Days FREE Trial $231M -2.1x 0.6x
PAPL Unlock Forecast - 30 Days FREE Trial $3M x 3.5x
PAPLF Unlock Forecast - 30 Days FREE Trial $98M x 116.9x
PGY Unlock Forecast - 30 Days FREE Trial $4401M x 12.0x
PGYWW Unlock Forecast - 30 Days FREE Trial $27M x 0.1x
PWP Unlock Forecast - 30 Days FREE Trial $0M -9.0x 0.0x
QFIN Unlock Forecast - 30 Days FREE Trial $8629M x 0.4x
RHLD Unlock Forecast - 30 Days FREE Trial $249M x 25.9x
RIOT Unlock Forecast - 30 Days FREE Trial $5525M 44.9x 1.7x
SAIH Unlock Forecast - 30 Days FREE Trial $-93M -2.1x 0.0x
SAIHW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SDIG Unlock Forecast - 30 Days FREE Trial $74M -0.6x 3.8x
SHFS Unlock Forecast - 30 Days FREE Trial $10M 5.0x -0.6x
SHFSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SLNH Unlock Forecast - 30 Days FREE Trial $9M -0.2x -0.5x
SLNHP Unlock Forecast - 30 Days FREE Trial $61M -0.8x -3.8x
SNFCA Unlock Forecast - 30 Days FREE Trial $216M 9.5x 0.6x
SOFI Unlock Forecast - 30 Days FREE Trial $23389M -103.2x 1.4x
SOS Unlock Forecast - 30 Days FREE Trial $439M x 1.0x
STRD Unlock Forecast - 30 Days FREE Trial $24822M 5.2x 0.5x
STRF Unlock Forecast - 30 Days FREE Trial $35210M 7.4x 0.7x
STRK Unlock Forecast - 30 Days FREE Trial $30071M 6.3x 0.6x
SYF Unlock Forecast - 30 Days FREE Trial $29226M 8.9x 1.7x
SYF-PA Unlock Forecast - 30 Days FREE Trial $7626M 2.3x 0.5x
SYF-PB Unlock Forecast - 30 Days FREE Trial $10047M 3.1x 0.6x
TAOX Unlock Forecast - 30 Days FREE Trial $16M x 0.9x
TRLC Unlock Forecast - 30 Days FREE Trial $47M 5.1x x
TRXA Unlock Forecast - 30 Days FREE Trial $16M x x
UPST Unlock Forecast - 30 Days FREE Trial $7111M -29.6x 9.9x
VEL Unlock Forecast - 30 Days FREE Trial $737M 9.1x 1.2x
VMNT Unlock Forecast - 30 Days FREE Trial $21M x x
WD Unlock Forecast - 30 Days FREE Trial $2873M 26.0x 1.6x
WINSF Unlock Forecast - 30 Days FREE Trial $14M x 0.1x
WULF Unlock Forecast - 30 Days FREE Trial $2094M -31.5x 12.3x

Frequently Asked Questions - Core Scientific, Inc./tx Stock Forecast

How accurate are Core Scientific, Inc./tx stock predictions?

Our AI model demonstrates 39% historical accuracy for CORZ predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Core Scientific, Inc./tx stock price forecasts?

Our analysis considers Core Scientific, Inc./tx's financial metrics, Finance or Crypto Assets sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Core Scientific, Inc./tx a good investment in 2025?

Based on our AI analysis, Core Scientific, Inc./tx shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Core Scientific, Inc./tx forecasts updated?

Core Scientific, Inc./tx stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Core Scientific, Inc./tx Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Core Scientific, Inc./tx stock.

My Portfolio

Investment Dashboard

Loading your portfolio...